PureForm BioSciences is a privately held, early stage biopharmaceutical company strategically aligned with the most important academic research institutions in the world. 


PureForm develops medical applications using proprietary bioidentical cannabinoids investigating novel drug delivery mechanisms and devices. 

PureForm's drug development pipeline addresses widespread indications that lack invention. This research will bring much needed treatments to the market.